BMI View: We uphold our view that Oman’s pharmaceuticals and healthcare markets will remain an
attractive investment proposition for multinational pharmaceutical companies. The public sector will
continue to fund the majority of healthcare expenditure in Oman. However, the private sector will play a
pivotal role in healthcare expansion over the long term as compulsory health insurance schemes gain
traction and the government looks to shift some of the financial burden. The rising cost of medical services
will be kept in check to an extent by the downward pressure on drug prices – mainly driven by the GCC’s
medicine price unification process. Over the long term, Oman’s population will benefit from more
affordable healthcare services as price unification becomes more standardised across the Gulf States.
Headline Expenditure Projections
? Pharmaceuticals: OMR242mn (USD629mn) in 2015 to OMR258mn (USD671mn) in 2016; 6.8% in
local currency and US dollar terms. Forecast in line with Q116.
? Healthcare: OMR942mn (USD2.45bn) in 2015 to OMR1.01bn (USD2.60bn) in 2016; +6.3% in local
currency and US dollar terms. Forecast in line with Q116.

Table of Contents

BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Oman 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Oman 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Oman 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Oman 2014-2020) 30
Industry Risk/Reward Index 31
Middle East and Africa Risk/Reward Index - Q2 2016 31
Oman Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 40
Intellectual Property Issues 41
Pricing Regime 42
Reimbursement Regime 44
Market Overview 45
Healthcare Sector 46
Table: Healthcare Resources (Oman 2010-2015) 47
Table: Healthcare Personnel (Oman 2010-2015) 48
Table: Healthcare Activity (Oman 2010-2015) 48
Research & Development 48
Clinical Trials 49
Epidemiology 50
Competitive Landscape 53
Research-Based Industry 53
Table: Multinational Market Activity 54
Generic Drugmakers 55
Pharmaceutical Distribution 56
Pharmaceutical Retail Sector 56
Company Profile 57
National Pharmaceutical Industries 57
Zynova/Oman Pharmaceutical Products Company 60
Demographic Forecast 63
Table: Population Headline Indicators (Oman 1990-2025) 64
Table: Key Population Ratios (Oman 1990-2025) 64
Table: Urban/Rural Population & Life Expectancy (Oman 1990-2025) 65
Table: Population By Age Group (Oman 1990-2025) 65
Table: Population By Age Group % (Oman 1990-2025) 66
Glossary 68
Methodology 70
Pharmaceutical Expenditure Forecast Model 70
Healthcare Expenditure Forecast Model 70
Notes On Methodology 71
Risk/Reward Index Methodology 72
Index Overview 73
Table: Pharmaceutical Risk/Reward Index Indicators 73
Indicator Weightings 74

List of Tables

Table: Headline Pharmaceuticals & Healthcare Forecasts (Oman 2014-2020)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Oman 2012-2020)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Oman 2012-2020)
Table: Pharmaceutical Trade Data And Forecasts (Oman 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Oman 2014-2020)
Table: Healthcare Resources (Oman 2010-2015)
Table: Healthcare Personnel (Oman 2010-2015)
Table: Healthcare Activity (Oman 2010-2015)
Table: Multinational Market Activity
Table: Population Headline Indicators (Oman 1990-2025)
Table: Key Population Ratios (Oman 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Oman 1990-2025)
Table: Population By Age Group (Oman 1990-2025)
Table: Population By Age Group % (Oman 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators